Noom / Noom Med Review: Who Handles Your Care From Assessment to Refill?

01Start by identifying who owes you which service

Noom, Inc. offers the website and app services, but its terms explicitly separate the platform from healthcare delivery. Accepting those terms does not establish a patient-clinician relationship with Noom itself. Instead, independent clinical partners provide medical and pharmacy services. A useful enrollment question is therefore not simply whether Noom offers clinician access, but which clinical organization will treat you and how to contact it when a prescription or health concern needs attention.

That division also applies to coaching. Noom’s terms say coaches cannot diagnose or treat medical or mental health conditions, and coaching interactions do not create a physician-patient relationship. Coaching may support behavior change, but it is not interchangeable with prescribing care. Our guide to the clinician-platform distinction explains why those separate responsibilities matter when a consumer-facing brand coordinates several services.

Noom Weight is the non-medication program and is available separately or included with medication plans. Its documented tools include food and macro tracking, progress tracking, body scans, coaching and personalized lessons. Those are tangible program features, not proof of a particular medical outcome. The documentation establishes a layered service—software and coaching alongside clinical access—rather than a single organization performing every step.

02Assessment comes before a prescribing decision

The pricing page describes a short online assessment, an eligibility and plan review, and connection with a clinician whom Noom describes as licensed. It says consumers will see pricing, subscription costs and next steps before committing. Eligibility varies by program and may involve BMI, medical history and state of residence. These descriptions document the intended process; they do not independently verify credentials or guarantee a prescription after payment.

The homepage excludes people under 18, people who are pregnant, people with an eating disorder and people who are underweight, defined there as BMI below 18.5. A Noom Med article updated in April 2025 also lists BMI of at least 30, or at least 27 with a weight-related condition. That older article should not be treated as the definitive eligibility rule for every current program, especially when the current pricing page says criteria vary.

The Wegovy pathway specifically describes a metabolic laboratory test before an online clinician evaluation, with prescribing only if clinically appropriate. The documentation does not establish which tests are mandatory or included across all other plans. Before enrolling, ask about test costs, where testing occurs and what happens if results require further evaluation. Preparing your history and questions using a first-consultation checklist is more useful than assuming an assessment is merely a checkout form.

03Choose the pathway before interpreting the price

Noom’s pricing page presents several distinct programs. The table preserves its introductory charges and billing language rather than treating each monthly figure as a standalone monthly subscription. For the medication-inclusive GLP-1 programs, the consulted documentation does not establish the exact molecule, formulation, route and presentation for every tier. A program name such as Microdose or Plus is therefore insufficient to identify what a patient would actually receive.

Plus is described as acting on both GLP-1 and GIP receptors, with clinical care, medication and the digital program included and no insurance required. Proactive Health separately lists $149 every four weeks, a first term of 15 weeks and 16-week renewals, plus home testing of 17 biomarkers and the same broad service inclusions. Those term lengths do not, by themselves, establish medication quantity, collection timing or a minimum commitment.

Other pages complicate the comparison. Homepage fine print advertises an initial three-week subscription with four weeks of medication from $149 plus tax, followed by $349 per month plus tax for a 12-week subscription; another offer starts from $79 plus tax, then $199 per month plus tax. Both specify new accounts and pricing effective March 31, 2026. The Wegovy page also displays $39/$129 and $69/$99 care-fee pairs, both excluding medication, without resolving their applicability.

04A prescription still needs an identifiable product and pharmacy

Noom advertises conditional access to medications including Ozempic, Wegovy and Zepbound, depending on clinician evaluation and the treatment plan. Its broader Noom Med article lists additional possible prescriptions, including Rybelsus, Mounjaro, Saxenda, Victoza, Trulicity, Contrave, metformin, topiramate and Bydureon. That list is not a promise that every medicine is available to every enrollee, nor does it identify which medicine is included in a particular advertised package.

The terms generally allow prescriptions to be dispensed at a patient’s chosen pharmacy. Exceptions matter: some compounded prescriptions can only be dispensed by a platform pharmacy partner, and certain generic programs require Noom’s preferred pharmacy to participate and obtain that program’s pricing. The consulted documentation does not name each dispensing pharmacy or provide independently checked licensing details. Ask for that information before assuming a prescription can be transferred locally.

Noom says GLP-1Rx medications are produced in USP-compliant, state-regulated pharmacies but have not been FDA-reviewed for safety, efficacy or quality. These are provider statements, not independent pharmacy verification. FDA says compounded preparations are not FDA approved and recommends them when an individual’s medical needs cannot be met by an approved drug. Nonapproval alone does not prove clinical inequivalence. A product-and-pharmacy check should establish the actual preparation rather than rely on an ingredient or program name.

05Coverage can change the route to medication

The branded-medication telehealth plan includes clinical care, a prescription when appropriate and the digital program, but not the medicine’s cost. Noom says it can help check potential insurance coverage; medication is then paid separately through insurance if approved or through cash payment. The pricing page says insurance does not cover the Noom program itself. Its insurance checker is informational and does not initiate treatment requests or issue prescriptions.

There is a separate employer or private-health-plan context. Noom’s terms say clinical partners may submit claims under those arrangements, with possible copays and deductibles. That is not necessarily inconsistent with the consumer pricing page, because the arrangements differ. The terms also say Noom is not enrolled as a participating provider or vendor in federal or state healthcare programs, including Medicare and Medicaid. Patients should distinguish platform fees, clinical claims and pharmacy coverage rather than assuming one insurance answer covers all three.

FSA/HSA reimbursement is described as possible, depending on the program, plan and provider—not guaranteed. The insurance-checker page promotes a first-month discount of $90 or more depending on program selection, while its starting-from-$39 figure refers only to the first-month subscription and excludes medication. Before authorizing payment, request a written summary separating the introductory charge, renewal collection, clinical services, medication, tests, taxes and any delivery charge.

06Shipping language leaves several clocks unresolved

The homepage advertises medication shipped to the patient’s door in seven days. The consulted language does not establish a guaranteed arrival deadline or clearly define when that period begins. Assessment, laboratory work, clinician review, prescribing, dispensing and carrier delivery are different events. A useful pre-enrollment question is which event starts the advertised clock and whom to contact if a prescription has been written but fulfillment has not moved forward.

Home delivery is not available for every medication and depends on insurance or cash-pay status. The branded-medication pathway allows pickup or pharmacy delivery, so enrollment does not necessarily mean a package will arrive from a Noom-selected pharmacy. The documentation also leaves cold-chain procedures, replacement arrangements and guaranteed dispensing or arrival times unresolved. Our guide to dispatch versus arrival explains the practical difference without turning a shipping claim into a delivery promise.

For injectable GLP-1 deliveries that arrive warm or with insufficient refrigeration, FDA explicitly advises not using the product and contacting the provider or dispensing pharmacy. The reviewed materials do not establish Noom-specific replacement terms for that situation. Before shipment, obtain the dispensing pharmacy’s contact information and ask how temperature concerns are assessed, who authorizes replacement and whether a replacement decision changes the next billing or refill date.

07Follow-up combines clinical access with behavioral tools

A Noom Med article advertises unlimited one-to-one telehealth visits and chat messaging with specially trained weight-loss clinicians. It also describes continuous access to a dedicated Care Team for insurance navigation where applicable, fulfillment, refills and potential side effects. Those are meaningful service claims, but the consulted documentation does not establish guaranteed human response times, a required review schedule or whether every current tier has identical access.

The digital component includes GLP-1 Companion with Muscle Defense, described as offering protein tracking, high-protein recipes and on-demand workouts. These are documented tools, not a verified guarantee of muscle preservation. For practical purposes, establish which channel serves each concern: coaching for habits, clinical messaging for treatment questions, the Care Team for coordination, and the pharmacy for dispensing or product questions. Confirm those routes within the plan actually offered to you.

NIDDK describes medication care as involving benefits, side effects, health conditions, other medicines and costs, with follow-up assessing tolerance and response—not just recurring payments. That makes appointment availability and escalation arrangements relevant purchasing questions. Noom’s public descriptions support the existence of ongoing clinical contact, but do not establish an individual care plan. The terms’ English-only contract provision also does not confirm whether clinical visits, messaging or consent materials are available in Spanish.

08Renewal and departure are part of care coordination

Subscriptions renew automatically at the end of the disclosed billing period unless canceled. The terms require cancellation before 11:59 p.m. Eastern on the day before the next recurring billing date, using the account cancellation process. A monthly advertised rate is not necessarily monthly collection: several pricing-page offers specify quarterly billing, and an older Noom Med article says plans are billed upfront for three months after the introductory month. Confirm the actual collection schedule at checkout.

Cancellation and refunds are separate. The terms ordinarily provide no refund or credit for partially used periods, while allowing discretionary exceptions. The refund policy says Noom Med refunds are no longer possible once a prescription is written. For Telehealth for Branded Meds, a refund may be available within seven days of the first charge, unless a clinical visit has occurred. Those boundaries can arrive before medication is dispensed or delivered.

These policies should not be read as eliminating every exception: the terms also describe a three-business-day rescission provision for California residents. Public cancellation guidance says access continues through the cycle, while the terms allow immediate cancellation effects during a trial or promotion. Before leaving, clarify remaining clinical access, pending prescriptions and refill responsibility. Stopping automatic renewal is an account action; it does not itself establish a clinical transition plan.

Questions & answers

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

1. FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
2. NIDDK: prescription medications for overweight and obesity ↗
3. Noom / Noom Med — official website ↗
4. Noom / Noom Med — med/wegovy ↗
5. Noom / Noom Med — terms and conditions of use ↗
6. Noom / Noom Med — insurance checker ↗
7. Noom / Noom Med — blog/weight management/noom program/what is noom med and how much does it cost and what do you get ↗
8. Noom / Noom Med — support/faqs/subscription and billing/2025/10/noom refund policy ↗
9. Noom / Noom Med — med/pricing ↗

Continue reading

• The GLP-1 Care Journey: Who Handles Intake, Prescribing, Delivery and Follow-Up?
• Who Provides Your Care When You Use a Telehealth Platform?
• From Prescription to Dispensing: Questions for the GLP-1 Pharmacy Handoff
• GLP-1 Approval, Dispatch and Arrival Are Different Clocks
• What Ongoing GLP-1 Support Actually Means